X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (222) 222
male (128) 128
oncology (128) 128
female (126) 126
middle aged (120) 120
aged (115) 115
chemotherapy (102) 102
adult (96) 96
cancer (91) 91
index medicus (83) 83
antineoplastic combined chemotherapy protocols - therapeutic use (66) 66
radiotherapy (66) 66
surgery (64) 64
combined modality therapy (63) 63
carcinoma, squamous cell - drug therapy (60) 60
head and neck neoplasms - drug therapy (60) 60
treatment outcome (58) 58
squamous-cell carcinoma (56) 56
neoplasm staging (47) 47
survival analysis (46) 46
cisplatin - administration & dosage (42) 42
head and neck cancer (41) 41
carcinoma (39) 39
aged, 80 and over (38) 38
carcinoma, squamous cell - pathology (38) 38
radiation-therapy (37) 37
survival (36) 36
adenocarcinoma (34) 34
antineoplastic combined chemotherapy protocols - adverse effects (34) 34
carcinoma, squamous cell - therapy (34) 34
head and neck neoplasms - pathology (34) 34
carcinoma, squamous cell - radiotherapy (33) 33
chemoradiotherapy (33) 33
esophageal cancer (32) 32
esophageal neoplasms - therapy (32) 32
care and treatment (31) 31
otorhinolaryngology (31) 31
prognosis (31) 31
esophageal neoplasms - pathology (30) 30
antineoplastic agents - therapeutic use (28) 28
carcinoma, squamous cell - mortality (28) 28
cisplatin (28) 28
survival rate (28) 28
article (27) 27
esophageal neoplasms - drug therapy (27) 27
head (27) 27
head and neck neoplasms - therapy (27) 27
retrospective studies (27) 27
adenocarcinoma - drug therapy (26) 26
chemotherapy, adjuvant (26) 26
carcinoma, squamous cell - surgery (25) 25
chemoradiation (25) 25
esophageal neoplasms - mortality (25) 25
adenocarcinoma - pathology (24) 24
disease-free survival (24) 24
fluorouracil - administration & dosage (24) 24
head and neck neoplasms - mortality (24) 24
neoadjuvant therapy (24) 24
radiation (24) 24
therapy (24) 24
adenocarcinoma - therapy (23) 23
clinical trials (23) 23
radiotherapy, adjuvant (23) 23
squamous cell carcinoma (23) 23
neck-cancer (22) 22
head and neck neoplasms - radiotherapy (21) 21
locally advanced head (21) 21
trial (21) 21
adenocarcinoma - mortality (20) 20
esophageal neoplasms - radiotherapy (20) 20
randomized-trial (20) 20
neck (19) 19
hematology, oncology and palliative medicine (18) 18
induction chemotherapy (18) 18
patient outcomes (18) 18
drug administration schedule (17) 17
esophageal neoplasms - surgery (17) 17
research (17) 17
united-states (17) 17
adenocarcinoma - radiotherapy (16) 16
cisplatin - therapeutic use (16) 16
esophagectomy (16) 16
organ preservation (16) 16
paclitaxel - administration & dosage (16) 16
radiotherapy dosage (16) 16
abridged index medicus (15) 15
adenocarcinoma - surgery (15) 15
cisplatin - adverse effects (15) 15
phase-ii trial (15) 15
prospective studies (15) 15
radiology, nuclear medicine & medical imaging (15) 15
clinical trials as topic (14) 14
follow-up studies (14) 14
growth-factor receptor (14) 14
head and neck neoplasms - surgery (14) 14
laryngeal neoplasms - therapy (14) 14
risk factors (14) 14
analysis (13) 13
esophagus (13) 13
expression (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2007, Volume 25, Issue 26, pp. 4110 - 4117
Journal Article
Journal Article
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 12/2001, Volume 345, Issue 26, pp. 1890 - 1900
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 34, pp. 8646 - 8654
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2/2008, Volume 100, Issue 4, pp. 261 - 269
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 697 - 710
Summary Background Previous trials have shown that anti-EGFR monoclonal antibodies can improve clinical outcomes of patients with recurrent or metastatic... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | P16 | ONCOLOGY | COLORECTAL-CANCER | OROPHARYNGEAL CANCER | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | III TRIAL | COOPERATIVE-ONCOLOGY-GROUP | PLUS FLUOROURACIL | Immunohistochemistry | South America | Head and Neck Neoplasms - virology | Prospective Studies | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Neoplasm Recurrence, Local - virology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | North America | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Head and Neck Neoplasms - chemistry | Neoplasm Metastasis | Carcinoma, Squamous Cell - mortality | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Fluorouracil - administration & dosage | Time Factors | Female | Retrospective Studies | Biomarkers, Tumor - analysis | Europe | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Squamous Cell - chemistry | Treatment Outcome | Papillomaviridae - isolation & purification | Neoplasm Recurrence, Local - chemistry | Head and Neck Neoplasms - pathology | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Biopsy | Carcinoma, Squamous Cell - secondary | Aged | Head and Neck Neoplasms - mortality | Care and treatment | Relapse | Carcinoma | Monoclonal antibodies | Product development | Metastasis | Cisplatin | Cancer | Diseases | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 11, pp. 1405 - 1414
Journal Article